ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...
Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others.
News Medical on MSN
Proimmune Ltd introduces Prove® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility
ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.
The Labaid Group is developing AI-based healthtech solutions and plans to establish 30 satellite cancer centres across Bangladesh to usher in a more precise healthcare. In an interview with The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback